title: Report of the Subcommittee on Control of Anticoagulation on the determination of the anticoagulant effects of apixaban: communication from the SSC of the ISTH.
authors.affiliation: Medical Faculty Mannheim, Department of Clinical Pharmacology, Ruprecht-Karls-University Heidelberg, Mannheim, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Harenberg
authors.forename: S
authors.initials: S
authors.lastname: Du
authors.forename: C
authors.initials: C
authors.lastname: Weiss
authors.forename: R
authors.initials: R
authors.lastname: Krämer
authors.forename: D
authors.initials: D
authors.lastname: Hoppensteadt
authors.forename: J
authors.initials: J
authors.lastname: Walenga
mesh_terms: D000925:Anticoagulants / Q000097:blood / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D001780:Blood Coagulation Tests / Q000592:standards*; D019411:Clinical Laboratory Techniques / Q000592:standards; D016903:Drug Monitoring / Q000592:standards; D017408:Guidelines as Topic; D006487:Hemostasis; D006801:Humans; D007391:International Cooperation; D011720:Pyrazoles / Q000097:blood / Q000627:therapeutic use*; D011728:Pyridones / Q000097:blood / Q000627:therapeutic use*; D015203:Reproducibility of Results; D013925:Thromboplastin / Q000737:chemistry; D013927:Thrombosis / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants; D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban; D013925:Thromboplastin